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Machine: B-Lines as Uncertain Measures on
Which to Base Clinical AssessmentRaso et al. (1) describe a software claimed as “a robust
approach for developing a portable device for the
individualized and automatic detection of pulmonary
interstitial edema or ﬁbrosis,” designed to detect
B-lines. We are concerned that these are merely ar-
tifacts without anatomic correspondence (2), which
cannot reasonably or reliably be considered markers
speciﬁc for any disease, pulmonary interstitial edema
or ﬁbrosis or otherwise. These ﬁndings are seen in
normal subjects, and even in pneumonectomized
patients, that is, where there is no lung present (2).
The ultrasound artifacts described in the preceding
text are particularly frequent when low-frequency
phased-array probes are used (1).
Moreover, in the light of the Razo and colleagues (1)
appropriate acknowledgement that B-lines cannot
be quantiﬁed exactly, we wonder whether a
soft computing-based B-line analysis through a
knowledge-based model for an objective, operator-
independent, automated, and quantitative classiﬁca-
tion of the severity of pulmonary interstitial syndrome
will amplify, or minimize, this a priori uncertainty of
measurements. Despite the claim that the model
correctly identiﬁed normal subjects in 100% of cases
and was able to discriminate the 3 levels of severity of
pulmonary interstitial edema and pulmonary ﬁbrosis,
apparently using the B-line count alone, we respect-
fully ask how the tool would perform in other condi-
tions, because the B-line count is also notoriously
operator- and setting-dependent (2), and whether this
procedure, acknowledged as nonspeciﬁc (1), is able to
detect and discriminate different superimposed or
overlapping conditions of similar appearance (2).
The description of laser-like vertical hyperechoic
reverberation artifacts moving synchronously withrespiration remind us of the artifacts seen in elec-
trocardiographic tracings of pulmonary edema and
several lung diseases. As your readers will be aware,
these artifacts are unrelated to electrical activity of
the heart, and do not reﬂect cardiac potentials on the
body surface; they merely distort the electrocardio-
gram and disappear with improvement or death,
exactly like B-lines.
Although, as Raso and colleagues (1) rightly claim,
an aid to diagnosis of such diseases by such a cost-
and time-efﬁcient manner could have a high impact
on public health, we note that the gold standard
considered in this case was still a physician with more
than 9 years’ experience (1). We wonder what objec-
tive measures were considered in the clinical
diagnoses (high-resolution computed tomography, or
pulse oxygen saturation, or even pulmonary auscul-
tation). It is unclear whether an imperfect model that
incorrectly classiﬁes 5% of patients, apparently stan-
dardized on the basis of the observations of a single
expert, without an interobserver variability report, is
sufﬁciently robust. We are indeed “moving toward
pervasive health care systems in human-oriented
environments,” but this will only be a good thing if
artiﬁcial intelligence and telemedicine are based on
robust, reliable measures, and not on the ghost in the
machine.Guglielmo M. Trovato, MD*
Marco Sperandeo, MD
*Department of Medical and Pediatric Science
The University Hospital of Catania
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the Machine: B-Lines as Uncertain Measures on
Which to Base Clinical AssessmentWe thank Drs. Trovato and Sperandeo for their inde-
fatigable interest in our work (1).
We understand that the artefactual nature of
B-lines may arouse skepticism. However, there is a
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1471large body of clinical and experimental evidence from
many different groups showing that multiple B-lines
are present when the pulmonary interstitium is
involved in a pathological process and are absent in a
normal lung. Recently, they have also been included
in European recommendation papers (2,3). We agree
that the underlying biophysical model is not yet fully
understood, but the clinical usefulness of this sign is
by now proven. After all, physicians successfully used
nitrates for decades to treat angina, despite being
unaware of nitric oxide and its speciﬁc physiological
mechanisms.
As stated in many papers, it is not only the mere
presence of B-lines that deﬁnes a positive evaluation.
We agree and have previously reported that a few B-
lines, especially at pulmonary bases, can be found in
normal subjects (4). In the case of pulmonary inter-
stitial syndrome, B-lines are multiple and diffuse in
the thorax, and if the etiology is systemic such as in
heart failure, they are bilateral. These characteristics
are very helpful for differentiating pathological con-
ditions from those in healthy subjects. It has also
been reported that there are some limitations of the
technique (4): patients with pneumonectomy fall into
this group.
To establish a diagnosis of heart failure or
pulmonary ﬁbrosis, we considered all clinical and
instrumental information available. Some of these
parameters are more “objective” (i.e., N-terminal pro–
B-type natriuretic peptide), some are less “objective”
(i.e., pulmonary auscultation). All parameters share
an accuracy that is never 100%, with false positives
and false negatives to be identiﬁed by the integration
of different data in a multiparametric approach. This
is why we always perform pulmonary auscultation,
but we know that we cannot rely only on auscultatoryﬁndings, given the low sensitivity and speciﬁcity for
most conditions (5).
We believe that diagnosis should not be made on
the basis of a single examination, but by integrating
anamnestic, clinical, and instrumental ﬁndings.Luna Gargani, MD
Rossella Raso, Eng, PhD*
Gennaro Tartarisco, Eng, PhD
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